A M Lefer1, R Scalia, D J Lefer. Show Affiliations » 1. Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA. allan.m.lefer@mail.tju.edu
Abstract
Entities: Chemical Disease Gene
Mesh： See more » Cardiovascular Diseases/drug therapyCardiovascular Diseases/immunologyCardiovascular Diseases/metabolismCoronary VesselsEndothelin-1/biosynthesisEndothelins/biosynthesisEndothelium, Vascular/drug effectsEndothelium, Vascular/immunologyEndothelium, Vascular/metabolismFibrinolytic Agents/therapeutic useFree Radical Scavengers/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useLovastatin/therapeutic useMuscle, Smooth, Vascular/drug effectsMuscle, Smooth, Vascular/metabolismNeutrophil Infiltration/drug effectsNitric Oxide/metabolismNitric Oxide Synthase/metabolismNitric Oxide Synthase Type IIIProtein Precursors/biosynthesisSimvastatin/therapeutic use
Substances： See more » Endothelin-1EndothelinsFibrinolytic AgentsFree Radical ScavengersHydroxymethylglutaryl-CoA Reductase InhibitorsProtein PrecursorsNitric OxideLovastatinSimvastatinNOS3 protein, humanNitric Oxide SynthaseNitric Oxide Synthase Type III
Year: 2001 PMID： 11164838 DOI： 10.1016/s0008-6363(00)00247-9
Source DB: PubMed Journal: Cardiovasc Res ISSN： 0008-6363 Impact factor: 10.787